Preliminary safety and biomarker results of the NLRP3 inflammasome inhibitor DFV890 in adult patients with myeloid diseases: A phase 1b study Meeting Abstract
| Authors: | Garcia-Manero, G.; Abaza, Y.; Greenberg, P. L.; Haque, T.; Kennedy, K. V.; Della Porta, M. G.; Ooi, M. G.; Stahl, M.; Xie, Z.; Mangaonkar, A. A.; Desai, P.; DeZern, A. E.; Garnier, A.; Meunier, M.; Pelizzari, A. M.; Platzbecker, U.; Sockel, K.; Kishtagari, A.; Lu, H.; Manganelli, L.; Ji, L.; Yan, Z.; Li, Y.; Roy, M.; Gatlik, E.; Singh, A.; Beaulieu, V.; Pelletier, M.; Rauch, P.; Gill, H. |
| Abstract Title: | Preliminary safety and biomarker results of the NLRP3 inflammasome inhibitor DFV890 in adult patients with myeloid diseases: A phase 1b study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 354 |
| End Page: | 355 |
| Language: | English |
| ACCESSION: | WOS:001412359600003 |
| DOI: | 10.1182/blood-2024-198326 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
